Moderna and Merck Develop Vaccine Cutting Risks of Skin Cancer

Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

More In Science

Can A.I. Help Us Learn More About Whales?

Explore the research being done using artificial intelligence to help us learn about the ocean's largest and most fascinating creatures. Watch!

What It's Like Swimming With A 6000 Pound Shark

Tom 'Blowfish' Hird talks swimming with one of the ocean's largest creatures and what else to expect from Shark Week on the Discovery Channel. Watch!

OS Therapies Revolutionizes Adolescent Osteosarcoma Treatment

OS Therapies is a therapeutic company targeting adolescent osteosarcoma, which is a bone-related cancer.

Why The GOP Wants To Stop The Cellular Agricultural Revolution

Author of 'Clean Meat,' Paul Shapiro joins Cheddar to discuss how the cellular agricultural revolution helps lower rates of foodborne illness and greatly improves environmental sustainability. Plus, how his company The Better Meat Co. is bringing healthier food options to the table.

Several U.S. Hospitals Return to Mask Mandates

Several U.S. Hospitals Return to Mask Mandates

Bristol Myers to Buy Cancer Drug Developer Rayzebio

Bristol Myers to Buy Cancer Drug Developer Rayzebio

Load More